Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-12

AUTHORS

Aiying Wang, Charles Dorso, Lisa Kopcho, Gregory Locke, Robert Langish, Eric Harstad, Petia Shipkova, Jovita Marcinkeviciene, Lawrence Hamann, Mark S Kirby

ABSTRACT

BACKGROUND: Dipeptidylpeptidase 4 (DPP4) inhibitors have clinical benefit in patients with type 2 diabetes mellitus by increasing levels of glucose-lowering incretin hormones, such as glucagon-like peptide -1 (GLP-1), a peptide with a short half life that is secreted for approximately 1 hour following a meal. Since drugs with prolonged binding to their target have been shown to maximize pharmacodynamic effects while minimizing drug levels, we developed a time-dependent inhibitor that has a half-life for dissociation from DPP4 close to the duration of the first phase of GLP-1 release. RESULTS: Saxagliptin and its active metabolite (5-hydroxysaxagliptin) are potent inhibitors of human DPP4 with prolonged dissociation from its active site (Ki = 1.3 nM and 2.6 nM, t1/2 = 50 and 23 minutes respectively at 37°C). In comparison, both vildagliptin (3.5 minutes) and sitagliptin ( < 2 minutes) rapidly dissociated from DPP4 at 37°C. Saxagliptin and 5-hydroxysaxagliptin are selective for inhibition of DPP4 versus other DPP family members and a large panel of other proteases, and have similar potency and efficacy across multiple species.Inhibition of plasma DPP activity is used as a biomarker in animal models and clinical trials. However, most DPP4 inhibitors are competitive with substrate and rapidly dissociate from DPP4; therefore, the type of substrate, volume of addition and final concentration of substrate in these assays can change measured inhibition. We show that unlike a rapidly dissociating DPP4 inhibitor, inhibition of plasma DPP activity by saxagliptin and 5-hydroxysaxagliptin in an ex vivo assay was not dependent on substrate concentration when substrate was added rapidly because saxagliptin and 5-hydroxysaxagliptin dissociate slowly from DPP4, once bound. We also show that substrate concentration was important for rapidly dissociating DPP4 inhibitors. CONCLUSIONS: Saxagliptin and its active metabolite are potent, selective inhibitors of DPP4, with prolonged dissociation from its active site. They also demonstrate prolonged inhibition of plasma DPP4 ex vivo in animal models, which implies that saxagliptin and 5-hydroxysaxagliptin would continue to inhibit DPP4 during rapid increases in substrates in vivo. More... »

PAGES

2

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2210-12-2

DOI

http://dx.doi.org/10.1186/1471-2210-12-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003409735

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22475049


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adamantane", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Algorithms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Artifacts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cloning, Molecular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dipeptidases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dipeptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dipeptidyl Peptidase 4", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dipeptidyl-Peptidase IV Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucagon-Like Peptide 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indicators and Reagents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macaca fascicularis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitriles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Binding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrrolidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sitagliptin Phosphate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Species Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triazoles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Departments of Metabolic Diseases - Diabetes, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Aiying", 
        "id": "sg:person.01104406417.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104406417.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Departments of Metabolic Diseases - Diabetes, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dorso", 
        "givenName": "Charles", 
        "id": "sg:person.01154604140.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154604140.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Chemical Enzymology, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kopcho", 
        "givenName": "Lisa", 
        "id": "sg:person.0661127156.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661127156.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Chemical Enzymology, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Locke", 
        "givenName": "Gregory", 
        "id": "sg:person.01007124715.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007124715.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Bioanalytical and Discovery Analytical Sciences, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Langish", 
        "givenName": "Robert", 
        "id": "sg:person.01001361225.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001361225.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Drug Safety Evaluation, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harstad", 
        "givenName": "Eric", 
        "id": "sg:person.0735774251.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735774251.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Bioanalytical and Discovery Analytical Sciences, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shipkova", 
        "givenName": "Petia", 
        "id": "sg:person.0655371307.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655371307.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Chemical Enzymology, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marcinkeviciene", 
        "givenName": "Jovita", 
        "id": "sg:person.01352457755.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352457755.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Chemistry, Research and Development, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamann", 
        "givenName": "Lawrence", 
        "id": "sg:person.01266750217.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266750217.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Departments of Metabolic Diseases - Diabetes, 08534, Pennington, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kirby", 
        "givenName": "Mark S", 
        "id": "sg:person.01123046465.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123046465.90"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1146/annurev.physiol.59.1.257", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004501539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db09-9028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004893088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-005-1705-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005545505", 
          "https://doi.org/10.1007/s00125-005-1705-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-005-1705-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005545505", 
          "https://doi.org/10.1007/s00125-005-1705-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-005-1705-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005545505", 
          "https://doi.org/10.1007/s00125-005-1705-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi990852f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006333706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi990852f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006333706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejphar.2009.09.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007530786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2006.01.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010001540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.abb.2005.11.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010449148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1592/phco.30.5.463", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015369957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2082", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017446919", 
          "https://doi.org/10.1038/nrd2082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2082", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017446919", 
          "https://doi.org/10.1038/nrd2082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14728222.11.7.967", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017883746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.febslet.2008.02.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019137463"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-009-0030-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020705132", 
          "https://doi.org/10.1007/s12325-009-0030-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-009-0030-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020705132", 
          "https://doi.org/10.1007/s12325-009-0030-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biocel.2005.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021537734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biocel.2005.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021537734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db06-0310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029686336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2007.03031.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030013452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/13543780903463862", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030565494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/9780470123072.ch5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030950782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02427280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032833398", 
          "https://doi.org/10.1007/bf02427280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02427280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032833398", 
          "https://doi.org/10.1007/bf02427280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02427280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032833398", 
          "https://doi.org/10.1007/bf02427280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2007.12.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034761236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12248-008-9041-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037130431", 
          "https://doi.org/10.1208/s12248-008-9041-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12248-008-9041-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037130431", 
          "https://doi.org/10.1208/s12248-008-9041-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.108.026088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038157524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm0493156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039282092"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm0493156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039282092"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs20090047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043907066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs20090047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043907066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/jpet.107.135723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045062629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci116186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051772692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm030091l", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055947906"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm030091l", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055947906"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm050261p", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055949517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm050261p", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055949517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2002-021053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064286286"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "BACKGROUND: Dipeptidylpeptidase 4 (DPP4) inhibitors have clinical benefit in patients with type 2 diabetes mellitus by increasing levels of glucose-lowering incretin hormones, such as glucagon-like peptide -1 (GLP-1), a peptide with a short half life that is secreted for approximately 1 hour following a meal. Since drugs with prolonged binding to their target have been shown to maximize pharmacodynamic effects while minimizing drug levels, we developed a time-dependent inhibitor that has a half-life for dissociation from DPP4 close to the duration of the first phase of GLP-1 release.\nRESULTS: Saxagliptin and its active metabolite (5-hydroxysaxagliptin) are potent inhibitors of human DPP4 with prolonged dissociation from its active site (Ki = 1.3 nM and 2.6 nM, t1/2 = 50 and 23 minutes respectively at 37\u00b0C). In comparison, both vildagliptin (3.5 minutes) and sitagliptin ( < 2 minutes) rapidly dissociated from DPP4 at 37\u00b0C. Saxagliptin and 5-hydroxysaxagliptin are selective for inhibition of DPP4 versus other DPP family members and a large panel of other proteases, and have similar potency and efficacy across multiple species.Inhibition of plasma DPP activity is used as a biomarker in animal models and clinical trials. However, most DPP4 inhibitors are competitive with substrate and rapidly dissociate from DPP4; therefore, the type of substrate, volume of addition and final concentration of substrate in these assays can change measured inhibition. We show that unlike a rapidly dissociating DPP4 inhibitor, inhibition of plasma DPP activity by saxagliptin and 5-hydroxysaxagliptin in an ex vivo assay was not dependent on substrate concentration when substrate was added rapidly because saxagliptin and 5-hydroxysaxagliptin dissociate slowly from DPP4, once bound. We also show that substrate concentration was important for rapidly dissociating DPP4 inhibitors.\nCONCLUSIONS: Saxagliptin and its active metabolite are potent, selective inhibitors of DPP4, with prolonged dissociation from its active site. They also demonstrate prolonged inhibition of plasma DPP4 ex vivo in animal models, which implies that saxagliptin and 5-hydroxysaxagliptin would continue to inhibit DPP4 during rapid increases in substrates in vivo.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-2210-12-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024637", 
        "issn": [
          "1471-2210"
        ], 
        "name": "BMC Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor", 
    "pagination": "2", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "103e10f4592d7e2ed687069edc84145bb9bc47ceb0522b6d3545603a75dba03f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22475049"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967806"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2210-12-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003409735"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2210-12-2", 
      "https://app.dimensions.ai/details/publication/pub.1003409735"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000503.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-2210-12-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2210-12-2'


 

This table displays all metadata directly associated to this object as RDF triples.

330 TRIPLES      21 PREDICATES      80 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2210-12-2 schema:about N0ada42a098ae4a74a65446dc1d17d582
2 N142ed561aa834f6686beb3fbc9048d3d
3 N16a7fc15f963451591e23c1c6dd967f4
4 N1b8686d8b61f4f0cb6a67719a4b9eef9
5 N3ae0385ca12d4cc5b77d09b5e8004394
6 N41286bb81263427fa2dd1e81d20b7f6c
7 N52432a965740436d89ef804cd6ef2423
8 N60619712684f47d1850b95fe68d53c9d
9 N61413058738e4d78bdd6efbc106fa735
10 N6384452124d6426a9f1b88b0607d9f73
11 N7fc36bf9747b4d87b508eebf1b4f7043
12 N88dc9677593b417abb8aec08f7bfbd8b
13 N8c2abc190741425db92c5fb489d08795
14 Na08954440a9644afaef3c2c062d3482f
15 Na1b97ea4ee40430f9998ba4f7394c233
16 Na53be345b0b8433f813444224a61b56e
17 Na6e8a94fd339491b8641c99d1e701382
18 Nac9941d6803448ad8c583633dd99823e
19 Nae0a0113d0a64360994c3ca4dfe2d4f2
20 Ne79b609de02e4282bfdd78349dcfb6c1
21 Neafba9d568574f26a3420f5102adeb14
22 Nf36f1c68b0e94e04ae7da9e32958d600
23 Nf753a775f7f24762ad135c277741540e
24 anzsrc-for:11
25 anzsrc-for:1103
26 schema:author N8427197c63be4f21950974bb67019017
27 schema:citation sg:pub.10.1007/bf02427280
28 sg:pub.10.1007/s00125-005-1705-7
29 sg:pub.10.1007/s12325-009-0030-9
30 sg:pub.10.1038/nrd2082
31 sg:pub.10.1208/s12248-008-9041-8
32 https://doi.org/10.1002/9780470123072.ch5
33 https://doi.org/10.1016/j.abb.2005.11.010
34 https://doi.org/10.1016/j.biocel.2005.07.011
35 https://doi.org/10.1016/j.clinthera.2006.01.015
36 https://doi.org/10.1016/j.clinthera.2007.12.034
37 https://doi.org/10.1016/j.ejphar.2009.09.027
38 https://doi.org/10.1016/j.febslet.2008.02.005
39 https://doi.org/10.1021/bi990852f
40 https://doi.org/10.1021/jm030091l
41 https://doi.org/10.1021/jm0493156
42 https://doi.org/10.1021/jm050261p
43 https://doi.org/10.1042/cs20090047
44 https://doi.org/10.1111/j.1365-2125.2007.03031.x
45 https://doi.org/10.1124/dmd.108.026088
46 https://doi.org/10.1124/jpet.107.135723
47 https://doi.org/10.1146/annurev.physiol.59.1.257
48 https://doi.org/10.1172/jci116186
49 https://doi.org/10.1210/jc.2002-021053
50 https://doi.org/10.1517/13543780903463862
51 https://doi.org/10.1517/14728222.11.7.967
52 https://doi.org/10.1592/phco.30.5.463
53 https://doi.org/10.2337/db06-0310
54 https://doi.org/10.2337/db09-9028
55 schema:datePublished 2012-12
56 schema:datePublishedReg 2012-12-01
57 schema:description BACKGROUND: Dipeptidylpeptidase 4 (DPP4) inhibitors have clinical benefit in patients with type 2 diabetes mellitus by increasing levels of glucose-lowering incretin hormones, such as glucagon-like peptide -1 (GLP-1), a peptide with a short half life that is secreted for approximately 1 hour following a meal. Since drugs with prolonged binding to their target have been shown to maximize pharmacodynamic effects while minimizing drug levels, we developed a time-dependent inhibitor that has a half-life for dissociation from DPP4 close to the duration of the first phase of GLP-1 release. RESULTS: Saxagliptin and its active metabolite (5-hydroxysaxagliptin) are potent inhibitors of human DPP4 with prolonged dissociation from its active site (Ki = 1.3 nM and 2.6 nM, t1/2 = 50 and 23 minutes respectively at 37°C). In comparison, both vildagliptin (3.5 minutes) and sitagliptin ( < 2 minutes) rapidly dissociated from DPP4 at 37°C. Saxagliptin and 5-hydroxysaxagliptin are selective for inhibition of DPP4 versus other DPP family members and a large panel of other proteases, and have similar potency and efficacy across multiple species.Inhibition of plasma DPP activity is used as a biomarker in animal models and clinical trials. However, most DPP4 inhibitors are competitive with substrate and rapidly dissociate from DPP4; therefore, the type of substrate, volume of addition and final concentration of substrate in these assays can change measured inhibition. We show that unlike a rapidly dissociating DPP4 inhibitor, inhibition of plasma DPP activity by saxagliptin and 5-hydroxysaxagliptin in an ex vivo assay was not dependent on substrate concentration when substrate was added rapidly because saxagliptin and 5-hydroxysaxagliptin dissociate slowly from DPP4, once bound. We also show that substrate concentration was important for rapidly dissociating DPP4 inhibitors. CONCLUSIONS: Saxagliptin and its active metabolite are potent, selective inhibitors of DPP4, with prolonged dissociation from its active site. They also demonstrate prolonged inhibition of plasma DPP4 ex vivo in animal models, which implies that saxagliptin and 5-hydroxysaxagliptin would continue to inhibit DPP4 during rapid increases in substrates in vivo.
58 schema:genre research_article
59 schema:inLanguage en
60 schema:isAccessibleForFree true
61 schema:isPartOf N4a0c0480c4074853a6d048476d0189a6
62 Nc981f3e4d6ec454089772b6eae4cfa51
63 sg:journal.1024637
64 schema:name Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor
65 schema:pagination 2
66 schema:productId N076d08f2bc06438e8b4919a62095ca20
67 N61ed08527ba04b7696b9dccc9f9c3207
68 N943bcf999a394362b915bc310af84464
69 N9f6c310a00574c048d277df84e51526a
70 Nddca7ce897814f78b49211c2bff23499
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003409735
72 https://doi.org/10.1186/1471-2210-12-2
73 schema:sdDatePublished 2019-04-10T21:34
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher Ne4c396867b114247b2b6b619abcc858f
76 schema:url http://link.springer.com/10.1186%2F1471-2210-12-2
77 sgo:license sg:explorer/license/
78 sgo:sdDataset articles
79 rdf:type schema:ScholarlyArticle
80 N050d43bf56ea449bb466dcf4ce512785 schema:name Chemical Enzymology, 08534, Pennington, NJ, USA
81 rdf:type schema:Organization
82 N076d08f2bc06438e8b4919a62095ca20 schema:name readcube_id
83 schema:value 103e10f4592d7e2ed687069edc84145bb9bc47ceb0522b6d3545603a75dba03f
84 rdf:type schema:PropertyValue
85 N0ac39ae0219f495fb6ad096a35d21589 schema:name Bioanalytical and Discovery Analytical Sciences, 08534, Pennington, NJ, USA
86 rdf:type schema:Organization
87 N0ada42a098ae4a74a65446dc1d17d582 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Indicators and Reagents
89 rdf:type schema:DefinedTerm
90 N12d2586f7d1043dbac874a182aa5f1af schema:name Chemical Enzymology, 08534, Pennington, NJ, USA
91 rdf:type schema:Organization
92 N142ed561aa834f6686beb3fbc9048d3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Nitriles
94 rdf:type schema:DefinedTerm
95 N16a7fc15f963451591e23c1c6dd967f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Algorithms
97 rdf:type schema:DefinedTerm
98 N16de55b7eba64f54813171ca4e906ade schema:name Departments of Metabolic Diseases - Diabetes, 08534, Pennington, NJ, USA
99 rdf:type schema:Organization
100 N1b3970633cb0460abba23aa023d6bd4f schema:name Departments of Metabolic Diseases - Diabetes, 08534, Pennington, NJ, USA
101 rdf:type schema:Organization
102 N1b8686d8b61f4f0cb6a67719a4b9eef9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Cloning, Molecular
104 rdf:type schema:DefinedTerm
105 N1f14ab9b489e43b48b2f51ef5e2315d8 rdf:first sg:person.01266750217.01
106 rdf:rest N67c0d191ec30440b9d8b1ed3031071b9
107 N2d4cfe9e588d4e86a4f0df64a36ab9e4 rdf:first sg:person.0655371307.13
108 rdf:rest N45743dc5b03e439dbbceaaf9771065b3
109 N3ae0385ca12d4cc5b77d09b5e8004394 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Sitagliptin Phosphate
111 rdf:type schema:DefinedTerm
112 N41286bb81263427fa2dd1e81d20b7f6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Hypoglycemic Agents
114 rdf:type schema:DefinedTerm
115 N4461bb95c21e4d54ac4e7155d416f23f rdf:first sg:person.0735774251.77
116 rdf:rest N2d4cfe9e588d4e86a4f0df64a36ab9e4
117 N45743dc5b03e439dbbceaaf9771065b3 rdf:first sg:person.01352457755.08
118 rdf:rest N1f14ab9b489e43b48b2f51ef5e2315d8
119 N4a0c0480c4074853a6d048476d0189a6 schema:issueNumber 1
120 rdf:type schema:PublicationIssue
121 N52432a965740436d89ef804cd6ef2423 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Triazoles
123 rdf:type schema:DefinedTerm
124 N60619712684f47d1850b95fe68d53c9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 N61413058738e4d78bdd6efbc106fa735 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Dipeptides
129 rdf:type schema:DefinedTerm
130 N61ed08527ba04b7696b9dccc9f9c3207 schema:name nlm_unique_id
131 schema:value 100967806
132 rdf:type schema:PropertyValue
133 N62912718b7bb49648266eabe9000825d schema:name Chemical Enzymology, 08534, Pennington, NJ, USA
134 rdf:type schema:Organization
135 N631dc7d144ac464cb9de3a295527a02c schema:name Bioanalytical and Discovery Analytical Sciences, 08534, Pennington, NJ, USA
136 rdf:type schema:Organization
137 N6384452124d6426a9f1b88b0607d9f73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Macaca fascicularis
139 rdf:type schema:DefinedTerm
140 N67c0d191ec30440b9d8b1ed3031071b9 rdf:first sg:person.01123046465.90
141 rdf:rest rdf:nil
142 N7fc36bf9747b4d87b508eebf1b4f7043 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Glucagon-Like Peptide 1
144 rdf:type schema:DefinedTerm
145 N8427197c63be4f21950974bb67019017 rdf:first sg:person.01104406417.12
146 rdf:rest Nf0c28ab3f8a94a8b8fcf2fd363d1e2b4
147 N88dc9677593b417abb8aec08f7bfbd8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Dipeptidyl-Peptidase IV Inhibitors
149 rdf:type schema:DefinedTerm
150 N8c2abc190741425db92c5fb489d08795 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
152 rdf:type schema:DefinedTerm
153 N943bcf999a394362b915bc310af84464 schema:name dimensions_id
154 schema:value pub.1003409735
155 rdf:type schema:PropertyValue
156 N9f53db1f9ef8453e825d6339f0ffbb55 schema:name Drug Safety Evaluation, 08534, Pennington, NJ, USA
157 rdf:type schema:Organization
158 N9f6c310a00574c048d277df84e51526a schema:name doi
159 schema:value 10.1186/1471-2210-12-2
160 rdf:type schema:PropertyValue
161 Na08954440a9644afaef3c2c062d3482f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Kinetics
163 rdf:type schema:DefinedTerm
164 Na1b97ea4ee40430f9998ba4f7394c233 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Pyrrolidines
166 rdf:type schema:DefinedTerm
167 Na45bacc4105546aa96bcfb3db5930569 schema:name Departments of Metabolic Diseases - Diabetes, 08534, Pennington, NJ, USA
168 rdf:type schema:Organization
169 Na53be345b0b8433f813444224a61b56e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Animals
171 rdf:type schema:DefinedTerm
172 Na6e8a94fd339491b8641c99d1e701382 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Dipeptidyl Peptidase 4
174 rdf:type schema:DefinedTerm
175 Nac9941d6803448ad8c583633dd99823e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Pyrazines
177 rdf:type schema:DefinedTerm
178 Nae0a0113d0a64360994c3ca4dfe2d4f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Species Specificity
180 rdf:type schema:DefinedTerm
181 Nbf78d336b4b54502a4dbe5f53e72a050 rdf:first sg:person.01001361225.99
182 rdf:rest N4461bb95c21e4d54ac4e7155d416f23f
183 Nc981f3e4d6ec454089772b6eae4cfa51 schema:volumeNumber 12
184 rdf:type schema:PublicationVolume
185 Nddca7ce897814f78b49211c2bff23499 schema:name pubmed_id
186 schema:value 22475049
187 rdf:type schema:PropertyValue
188 Ne4c396867b114247b2b6b619abcc858f schema:name Springer Nature - SN SciGraph project
189 rdf:type schema:Organization
190 Ne79b609de02e4282bfdd78349dcfb6c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Artifacts
192 rdf:type schema:DefinedTerm
193 Neafba9d568574f26a3420f5102adeb14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Dipeptidases
195 rdf:type schema:DefinedTerm
196 Nf0c28ab3f8a94a8b8fcf2fd363d1e2b4 rdf:first sg:person.01154604140.91
197 rdf:rest Nf8a9dcee4a2343628985d50c2af62642
198 Nf2d749626e2f42c4ad0591903f58403a rdf:first sg:person.01007124715.70
199 rdf:rest Nbf78d336b4b54502a4dbe5f53e72a050
200 Nf36f1c68b0e94e04ae7da9e32958d600 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Protein Binding
202 rdf:type schema:DefinedTerm
203 Nf753a775f7f24762ad135c277741540e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Adamantane
205 rdf:type schema:DefinedTerm
206 Nf8a9dcee4a2343628985d50c2af62642 rdf:first sg:person.0661127156.38
207 rdf:rest Nf2d749626e2f42c4ad0591903f58403a
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
212 schema:name Clinical Sciences
213 rdf:type schema:DefinedTerm
214 sg:journal.1024637 schema:issn 1471-2210
215 schema:name BMC Pharmacology
216 rdf:type schema:Periodical
217 sg:person.01001361225.99 schema:affiliation N0ac39ae0219f495fb6ad096a35d21589
218 schema:familyName Langish
219 schema:givenName Robert
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001361225.99
221 rdf:type schema:Person
222 sg:person.01007124715.70 schema:affiliation N050d43bf56ea449bb466dcf4ce512785
223 schema:familyName Locke
224 schema:givenName Gregory
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007124715.70
226 rdf:type schema:Person
227 sg:person.01104406417.12 schema:affiliation N1b3970633cb0460abba23aa023d6bd4f
228 schema:familyName Wang
229 schema:givenName Aiying
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104406417.12
231 rdf:type schema:Person
232 sg:person.01123046465.90 schema:affiliation Na45bacc4105546aa96bcfb3db5930569
233 schema:familyName Kirby
234 schema:givenName Mark S
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123046465.90
236 rdf:type schema:Person
237 sg:person.01154604140.91 schema:affiliation N16de55b7eba64f54813171ca4e906ade
238 schema:familyName Dorso
239 schema:givenName Charles
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154604140.91
241 rdf:type schema:Person
242 sg:person.01266750217.01 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
243 schema:familyName Hamann
244 schema:givenName Lawrence
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266750217.01
246 rdf:type schema:Person
247 sg:person.01352457755.08 schema:affiliation N62912718b7bb49648266eabe9000825d
248 schema:familyName Marcinkeviciene
249 schema:givenName Jovita
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352457755.08
251 rdf:type schema:Person
252 sg:person.0655371307.13 schema:affiliation N631dc7d144ac464cb9de3a295527a02c
253 schema:familyName Shipkova
254 schema:givenName Petia
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655371307.13
256 rdf:type schema:Person
257 sg:person.0661127156.38 schema:affiliation N12d2586f7d1043dbac874a182aa5f1af
258 schema:familyName Kopcho
259 schema:givenName Lisa
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661127156.38
261 rdf:type schema:Person
262 sg:person.0735774251.77 schema:affiliation N9f53db1f9ef8453e825d6339f0ffbb55
263 schema:familyName Harstad
264 schema:givenName Eric
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735774251.77
266 rdf:type schema:Person
267 sg:pub.10.1007/bf02427280 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032833398
268 https://doi.org/10.1007/bf02427280
269 rdf:type schema:CreativeWork
270 sg:pub.10.1007/s00125-005-1705-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005545505
271 https://doi.org/10.1007/s00125-005-1705-7
272 rdf:type schema:CreativeWork
273 sg:pub.10.1007/s12325-009-0030-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020705132
274 https://doi.org/10.1007/s12325-009-0030-9
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/nrd2082 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017446919
277 https://doi.org/10.1038/nrd2082
278 rdf:type schema:CreativeWork
279 sg:pub.10.1208/s12248-008-9041-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037130431
280 https://doi.org/10.1208/s12248-008-9041-8
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1002/9780470123072.ch5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030950782
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1016/j.abb.2005.11.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010449148
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/j.biocel.2005.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021537734
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.clinthera.2006.01.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010001540
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/j.clinthera.2007.12.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034761236
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/j.ejphar.2009.09.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007530786
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/j.febslet.2008.02.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019137463
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1021/bi990852f schema:sameAs https://app.dimensions.ai/details/publication/pub.1006333706
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1021/jm030091l schema:sameAs https://app.dimensions.ai/details/publication/pub.1055947906
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1021/jm0493156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039282092
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1021/jm050261p schema:sameAs https://app.dimensions.ai/details/publication/pub.1055949517
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1042/cs20090047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043907066
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1111/j.1365-2125.2007.03031.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030013452
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1124/dmd.108.026088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038157524
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1124/jpet.107.135723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045062629
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1146/annurev.physiol.59.1.257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004501539
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1172/jci116186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051772692
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1210/jc.2002-021053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064286286
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1517/13543780903463862 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030565494
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1517/14728222.11.7.967 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017883746
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1592/phco.30.5.463 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015369957
323 rdf:type schema:CreativeWork
324 https://doi.org/10.2337/db06-0310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029686336
325 rdf:type schema:CreativeWork
326 https://doi.org/10.2337/db09-9028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004893088
327 rdf:type schema:CreativeWork
328 https://www.grid.ac/institutes/grid.419971.3 schema:alternateName Bristol-Myers Squibb (United States)
329 schema:name Chemistry, Research and Development, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, 08534, Pennington, NJ, USA
330 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...